Braavos Capital Gp Limited investment portfolio

OXEHEALTH LIMITED provides a vision-based patient monitoring and management platform called Oxevision, which uses camera-based hardware and AI software for contactless patient observation, vital sign measurement, and activity monitoring. The company primarily serves inpatient settings such as mental health hospitals, care homes, skilled nursing facilities, prisons, and police forces in the UK, Europe, and the US.

SpyBiotech Limited develops vaccine platform technologies based on its proprietary protein “superglue” (SpyTag/SpyCatcher) system, enabling rapid assembly of vaccine components for infectious diseases, cancer and chronic diseases. The company targets the healthcare market by offering these vaccine solutions to collaborators, investors and therapeutic developers.